Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Responses in Oncology Patients to Novel Coronavirus Vaccines (IROC)

NCT04930055 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT04930055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04930055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Responses in Oncology Patients to Novel Coronavirus Vaccines (IROC)
Lead sponsor
Indiana University
Phase
Observational
Overall status
Terminated
Start date
June 30, 2021
Completion date
March 8, 2022
Enrollment
2,206 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer